Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Mouth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04197986
What this trial is testing

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

Who this might be right for
Upper Tract Urothelial CarcinomasUrothelial Bladder Cancer
QED Therapeutics, a BridgeBio company 39
Testing effectiveness (Phase 2)UnknownNCT02735317
What this trial is testing

Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT

Who this might be right for
Nasopharyngeal NeoplasmsStomatitis
Yun-fei Xia 90
Not applicableLooking for participantsNCT04007783
What this trial is testing

Validation of the O-bridge Protocol: a Prospective, Multicenter Trial

Who this might be right for
Benign or Malignant Tumour of the Oral CavityStage III-IV OsteonecrosisMandibular Reconstruction+2 more
AZ Sint-Jan AV 80
Post-approval studies (Phase 4)Study completedNCT00365508
What this trial is testing

Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Fox Chase Cancer Center 642
Testing effectiveness (Phase 2)Study completedNCT02654990
What this trial is testing

Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
pharmaand GmbH 248
Early research (Phase 1)Active Not RecruitingNCT02993146
What this trial is testing

Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Brain
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT00267046
What this trial is testing

Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma

Who this might be right for
SarcomaOral Mucositis
M.D. Anderson Cancer Center 49
Early research (Phase 1)Not Yet RecruitingNCT07611370
What this trial is testing

Evaluating the Effects of Propionate and Butyrate Supplementation on the Intestinal Health of Healthy Volunteers

Who this might be right for
Graft Versus Host DiseaseHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
City of Hope Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT06380686
What this trial is testing

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

Who this might be right for
Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the Hypopharynx+1 more
AIO-Studien-gGmbH 120
Early research (Phase 1)Study completedNCT01266954
What this trial is testing

An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer

Who this might be right for
Solid Tumours
GlaxoSmithKline 36
Testing effectiveness (Phase 2)Study completedNCT00524017
What this trial is testing

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Who this might be right for
Head and Neck CancerPrecancerous Condition
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Not applicableStudy completedNCT02648789
What this trial is testing

Validation of DNA Methylation Biomarkers for Oral Cancer Detection

Who this might be right for
Oral CancerRecurrence
Taipei Veterans General Hospital, Taiwan 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Early research (Phase 1)Study completedNCT01992874
What this trial is testing

Relative Bioavailability of Pimasertib in Cancer Patients

Who this might be right for
Neoplasms
EMD Serono 38
Large-scale testing (Phase 3)Study completedNCT01414790
What this trial is testing

The Use of Human Acellular Dermal Matrix to Improve Infraauricular Depressed Deformities and Frey's Syndrome

Who this might be right for
Parotid Tumor
West China Hospital 70
Testing effectiveness (Phase 2)Study completedNCT04529850
What this trial is testing

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral Mucositis
Galera Therapeutics, Inc. 38
Early research (Phase 1)Looking for participantsNCT06926413
What this trial is testing

A Study Evaluating the Effect of Aumolertinib on the Pharmacokinetics of Midazolam in Patients With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 20
Not applicableLooking for participantsNCT05483374
What this trial is testing

The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers

Who this might be right for
Head and Neck CancerNasopharynx CancerNasal Cavity and Paranasal Sinus Cancer+2 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 13,600
Large-scale testing (Phase 3)Temporarily pausedNCT01810913
What this trial is testing

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Who this might be right for
Oropharyngeal p16INK4a-Negative Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7+6 more
National Cancer Institute (NCI) 613
Next Page